4.0 out of 5 from our editorial team, reflecting strong pricing fundamentals and transparent pharmacy sourcing weighed against the complete absence of independent patient reviews
Wegovy (semaglutide 2.4 mg) is a once-weekly injectable medication licensed in the UK for weight management in adults with obesity or those who are overweight with weight-related health conditions
2018 Mar 29;9(1):1286
Mounjaro and Vision Changes 2026 Update July 2026: There are currently 146 pending claims in the MDL for patients alleging that GLP-1 drugs, including Mounjaro, led them to develop NAION (vision loss)
Brand-name drugs are subject to pharmaceutical company pricing, which can be significantly higher due to research, development, and marketing costs and corporate profitability
CVS Caremark will provide advanced communication and/or support to customers, consultants, providers and members to help ensure a smooth transition to covered therapies